Status:
TERMINATED
Postpartum Management of Gestational Hypertensive Disorders Using Furosemide
Lead Sponsor:
Wright State University
Conditions:
Hypertension, Pregnancy-Induced
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
* The main purpose of this study is to learn if incorporating a loop diuretic such as furosemide along with labetalol in the routine management of postpartum gestational hypertensive disorders could l...
Detailed Description
Background and Literature Review * There have been four documented studies investigating loop diuretics in the management of postpartum hypertensive disorders- Matthews et al2, Ascarelli et al3, Amor...
Eligibility Criteria
Inclusion
- Postpartum women delivering at Miami Valley Hospital
- Diagnosis of gestational hypertension or preeclampsia
- Able to provide written informed consent
Exclusion
- Diagnosis of chronic hypertension
- Allergy to study medications
- Unable to understand English
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04343235
Start Date
May 1 2020
End Date
June 30 2022
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miami Valley Hospital
Dayton, Ohio, United States, 45409